The Canadian Breast Cancer Symposium 2025: Meeting Report.

Curr Oncol · 2025 · PMC12839805 · PMID 41590335

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

An exploratory post hoc analysis of the phase 3 PENELOPE-B trial showed a trend in improved survival and invasive disease-free survival with palbociclib at 6 years in the subgroup of patients with lobular breast cancer [ 126 ].

also in 53,322 other papers

an increasing trendno p-value reported

An outstanding question is the role of RT alone in the setting of an increasing trend toward omission of sentinel lymph node biopsy (SLNB). 3.1.2.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.